Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Generic Palbociclib is safe and tolerable for treating certain breast cancer types.

AMP-303 safely increases hair growth in men with hair loss.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Abatacept may help some people with alopecia areata regrow hair.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Presurgical models can effectively and affordably screen cancer prevention agents.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

Thermobalancing therapy is safe and effective for treating enlarged prostates.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

The measures for eyebrow and eyelash hair loss in severe Alopecia Areata are reliable and useful for clinical trials.

Upadacitinib effectively treats severe alopecia areata and is safe.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

BCG injection helps reduce long COVID symptoms and affects hair loss differently in men and women.

Monthly oral corticosteroid pulses effectively treat widespread alopecia areata in young patients.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Alefacept does not effectively treat severe alopecia areata.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Baricitinib works better than methotrexate for severe alopecia areata.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.